Register for APTA CSM in Philadelphia by Nov. 4 to save with early bird rates.
By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
Includes articles, courses, and CPGs. Unlimited access for APTA members.
Individuals with LEP can include those with sensory impairments, who are Deaf or hard of hearing and communicate using ASL, have speech impairments, or who are blind or have visual impairments.
Feb 27, 2018/Article
These voluntary Academic Coordinator/Director of Clinical Education Performance Assessments are being made available as a resource for use by PT and PTA academic programs.
Jul 30, 2020/Article
These five federal fraud and abuse laws are important for physical therapists to know.
This award honors recent fellowship graduates in order to recognize the intrinsic value of post-professional training and thereby promote and provide for the development and accreditation of fellowship education programs in physical therapy.
Jan 1, 2022/Article
Access considerations, guidelines, tools and resources to help you with general clinical decision-making in physical therapist practice.
Aug 3, 2020/Article
Review and understand the key terms of health care fraud, abuse, and waste to prevent and mitigate risks in your practice.
Jan 1, 2026/Policies & Bylaws
The vision of the American Physical Therapy Association is "transforming society by optimizing movement to improve the human experience." Our profession’s charge, as we strive to be an inclusive moral community that is diverse and equitable, is to meet the health needs of all people.
Sep 30, 2023/CPG
Dec 11, 2025/Policies & Bylaws
BOD Y11-25-04-01: This policy establishes standardized language usage in the development of Association policies, positions, and recommendations to the Board of Directors. It ensures clarity, consistency, and appropriate interpretation of intent and resource implications.
Oct 3, 2025/CPG
This evidence-based care guideline from Cincinnati Children’s Hospital provides recommendations for therapeutic management of pediatric and adolescent joint hypermobility and hypermobility spectrum disorder, including hypermobile Ehlers-Danlos syndrome. It does not address children and adolescents with
